Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 1,975 startups that have raised more than $4.3 billion in funding, generated more than $2.5 billion in revenue, and created more than 121,000 total jobs. 

Our startups

Be inspired. Search our startups.

Clear  
Tellus Therapeutics
Tellus Therapeutics

One in ten babies is born premature and at significant risk for white matter (myelin) injury and subsequent life-long cognitive and neurological impairments, such as cerebral palsy. Tellus is developing novel small molecules derived from human breast milk shown to regenerate myelin-producing oligodendrocytes and reverse white matter injury in neonatal animal models and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury for whom no treatments exist.
Tellus is developing novel small molecules derived from human breast milk to reverse the neonatal brain injury that leads to cerebral palsy.

Connect with Tellus Therapeutics

2019

2019 Finalist Boston

Sub industry

Therapeutics (Pharma / Biotech)

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.